Recruiting

Ketogenic Therapy

Sponsor:

Stanford University

Code:

NCT06748950

Conditions

Schizophrenia

Schizophrenia and Related Disorders

Bipolar Disorder

Bipolar and Related Disorders

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LCHF Ketogenic Diet

Diet-as-Usual (DAU)

Study Details

Brief summary:

The goal of this randomized clinical trial is to be adequately powered to evaluate the effect of ketogenic metabolic therapy on the quality of life in serious mental illness, schizophrenia, bipolar disorder, major depressive disorder.

Conditions

Schizophrenia

Schizophrenia and Related Disorders

Bipolar Disorder

Bipolar and Related Disorders

Major Depressive Disorder

Study ID

NCT06748950

Start date

Oct 19, 2026

Status verified date

Nov, 2026

Completion date

Jun, 2029

Anticipated

Primary completion date

Dec, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. diagnosed with bipolar disorder (BD), major depressive disorder (MDD), and or schizophrenia

1. For individuals diagnosed with bipolar disorder (BD):

  • Meet DSM V criteria for BD (any subtype)
  • clinically stable (with no hospitalization for past 3 months)
2. For individuals diagnosed with major depressive disorder (MDD):

• clinically stable (with no hospitalization for past 3 months)
3. For individuals diagnosed with schizophrenia:

  • Meet DSM V criteria for schizophrenia (any subtype)
  • clinically stable (with no hospitalization for past 3 months)
2. Participants may currently be on a stable and adequate dose of SSRI antidepressant therapy or other psychiatric medication. Concurrent hypnotic therapy (e.g., with zolpidem, zaleplon, melatonin, or trazodone) will be allowed if the therapy has been stable for at least four weeks prior to screening and if it is expected to remain stable. Participants may be switched from other classes of medication to another medication class by their psychiatrist or primary care doctor, but need to be stable enough to enroll and adhere to study procedures.
3. willing and able to give informed consent for participation in English.
4. live within the United States.

\--------------------------------------------------------------------------------

Exclusion Criteria:

1. has started the ketogenic diet or was in ketosis within 3 months of wanting to enroll
2. pregnant or nursing
3. insulin dependent
4. comorbidity of developmental delay
5. in a current severe mood or psychotic state when entering the study that would prohibit compliance with study visits or dietary programs.
6. any one who has been hospitalized or taken clozapine at doses above 550mg over the past 3 months
7. inability to complete baseline measurements
8. severe renal or hepatic insufficiency
9. cardiovascular dysfunction, including diagnosis of:

  • Congestive heart failure
  • Angina
  • Arrhythmias
  • Cardiomyopathy
  • Valvular heart disease
10. active substance abuse with illicit drugs or alcohol and/or current diagnosis of a Substance Use Disorder (Abuse or Dependence, as defined by DSM-IV-TR), with the exception of nicotine or cannabis dependence
11. active suicidal and considered at significant risk for suicide during course of study
12. participation in any clinical trial- within the past month or concurrent to study participation- with an investigational drug/device and/or intervention that may interfere with study participation/evaluation of results
13. any other medical condition that may make diet intervention dangerous as determined by the study medical team (e.g. anorexia nervosa) or assessed by study team to have insufficient control over their food intake to adhere to study diets.
14. any medical condition that physicians or the PI believe would interfere with study participation or evaluation of results
15. history of familial hypercholesterolemia

Study Design

Enrollment

120 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Arm 1: Ketogenic Diet Only

Participants will follow 12 weeks of the ketogenic diet, with monitoring of physical and psychological health and coaching support.

experimental: Arm 2: DAU- Ketogenic Diet Crossover

Participants will follow 12 weeks of their usual diet (Diet-as-Usual, DAU). Then, participants will crossover and follow 12 weeks of the ketogenic diet. Monitoring of physical and psychological health and coaching support will occur throughout participation.

Interventions

LCHF Ketogenic Diet

Low Carbohydrate, Moderate Protein, High Fat (LCHF) Ketogenic Dietary Intervention for 12 weeks

Diet-as-Usual (DAU)

Participant's usual diet

Primary outcome measure

  • WHO-5 Well-being Index [ Time Frame: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover). ]
  • Functioning Assessment Short Test (FAST) [ Time Frame: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover). ]
  • Quality of Life Scale (QIDS) [ Time Frame: Baseline through study completion, an average of 12 weeks (Arm 1: Ketogenic Diet Only) or 24 weeks (Arm 2: DAU-Ketogenic Diet Crossover). ]

Central Contacts and Locations

Central contacts

Locations

Stanford University

Recruiting

Palo Alto, California, United States, 94304

Contacts

Jessi W Study Coordinators, CRA

(650) 725-0169jessili@stanford.edu

Principal Investigator:

Shebani Sethi, MD

More Information

Sponsor

Stanford University

Last update posted

Nov 16, 2026

Last verified

Nov, 2026

Keywords

  • Mental Illness
  • Multiomics
  • Multi-omics
  • Omics Profiling

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Stanford University on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.